(Q70365259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Phasic approach to oral contraceptives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

R W Hale

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 October 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Obstetrics and Gynecology

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

4 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

1052-1058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Oral contraceptives and cardiovascular disease (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Oral contraceptives and cardiovascular disease (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

The endocrinology of the menstrual cycle: the interaction of folliculogenesis and neuroendocrine mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2887%2980131-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(87)80131-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3118718%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference